Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

作者: G. C. Parkes , N. B. Rayment , B. N. Hudspith , L. Petrovska , M. C. Lomer

DOI: 10.1111/J.1365-2982.2011.01803.X

关键词: Irritable bowel syndromeEubacteriumConstipationBiologyColonoscopyBiopsyBacteroidesGastroenterologyEtiologyDiarrheaInternal medicine

摘要: Background  There is increasing evidence to support a role for the gastrointestinal microbiota in etiology of irritable bowel syndrome (IBS). Given an inflammatory component IBS, mucosa-associated potentially play key its pathogenesis. The objectives were compare between patients with diarrhea predominant IBS (IBS-D), constipation (IBS-C) and controls using fluorescent situ hybridization correlate specific bacteria groups individual symptoms. Methods  Forty-seven (27 IBS-D 20 IBS-C) 26 healthy recruited study. Snap-frozen rectal biopsies taken at colonoscopy bacterial quantification performed by hybridizing frozen sections bacterial-group oligonucleotide probes. Key Results  Patients had significantly greater numbers total per mm epithelium than [median 218 (IQR – 209) vs 128 (121) P = 0.007], this was chiefly comprised bacteroides [69 (67) 14 (41) P = 0.001] Eubacterium rectale–Clostridium coccoides [52 (58) 25 (35) P = 0.03]. Analysis sub-groups demonstrated that bifidobacteria lower group IBS-C [24 (32) 54 (88) 32 P = 0.011]. Finally, amongst maximum number stools day negatively correlated (P < 0.001) lactobacilli (P = 0.002). Conclusions & Inferences  different from increases clostridia reduction IBS-D.

参考文章(46)
G Poli, E Fesce, A Ceccarelli, F Dubini, A Balsari, The Fecal Microbial Population in the Irritable Bowel Syndrome Microbiologica. ,vol. 5, pp. 185- 194 ,(1982)
Jian-Min Si, Intestinal Microecology and Quality of Life in Irritable Bowel Syndrome Patients World Journal of Gastroenterology. ,vol. 10, pp. 1802- 1805 ,(2004) , 10.3748/WJG.V10.I12.1802
G J Jansen, G C Raangs, G R Kamphuis, M H Wilkinson, G W Welling, P S Langendijk, F Schut, Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Applied and Environmental Microbiology. ,vol. 61, pp. 3069- 3075 ,(1995) , 10.1128/AEM.61.8.3069-3075.1995
K. KAJANDER, E. MYLLYLUOMA, M. RAJILIĆ-STOJANOVIĆ, S. KYRÖNPALO, M. RASMUSSEN, S. JÄRVENPÄÄ, E. G. ZOETENDAL, W. M. DE VOS, H. VAPAATALO, R. KORPELA, Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota Alimentary Pharmacology & Therapeutics. ,vol. 27, pp. 48- 57 ,(2007) , 10.1111/J.1365-2036.2007.03542.X
R I Amann, B J Binder, R J Olson, S W Chisholm, R Devereux, D A Stahl, Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Applied and Environmental Microbiology. ,vol. 56, pp. 1919- 1925 ,(1990) , 10.1128/AEM.56.6.1919-1925.1990
L K Poulsen, T R Licht, C Rang, K A Krogfelt, S Molin, Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. Journal of Bacteriology. ,vol. 177, pp. 5840- 5845 ,(1995) , 10.1128/JB.177.20.5840-5845.1995
A. P. S. Hungin, P. J. Whorwell, J. Tack, F. Mearin, The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Alimentary Pharmacology & Therapeutics. ,vol. 17, pp. 643- 650 ,(2003) , 10.1046/J.1365-2036.2003.01456.X
Akinori Koide, Taketo Yamaguchi, Takeo Odaka, Hidehiko Koyama, Toshio Tsuyuguchi, Hiroshi Kitahara, Masao Ohto, Hiromitsu Saisho, Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. The American Journal of Gastroenterology. ,vol. 95, pp. 1735- 1741 ,(2000) , 10.1111/J.1572-0241.2000.02189.X
Anna Accarino, Frederic Perez, Fernando Azpiroz, Sergi Quiroga, Juan–R. Malagelada, Abdominal Distention Results From Caudo-ventral Redistribution of Contents Gastroenterology. ,vol. 136, pp. 1544- 1551 ,(2009) , 10.1053/J.GASTRO.2009.01.067
D. B. A. SILK, A. DAVIS, J. VULEVIC, G. TZORTZIS, G. R. GIBSON, Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. ,vol. 29, pp. 508- 518 ,(2009) , 10.1111/J.1365-2036.2008.03911.X